261 related articles for article (PubMed ID: 29545333)
1. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
[TBL] [Abstract][Full Text] [Related]
2. miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers.
Langsch S; Baumgartner U; Haemmig S; Schlup C; Schäfer SC; Berezowska S; Rieger G; Dorn P; Tschan MP; Vassella E
Cancer Res; 2016 Jul; 76(14):4160-9. PubMed ID: 27199349
[TBL] [Abstract][Full Text] [Related]
3. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
[TBL] [Abstract][Full Text] [Related]
4. NF-κB maintains the stemness of colon cancer cells by downregulating miR-195-5p/497-5p and upregulating MCM2.
Wang L; Guo J; Zhou J; Wang D; Kang X; Zhou L
J Exp Clin Cancer Res; 2020 Oct; 39(1):225. PubMed ID: 33109220
[TBL] [Abstract][Full Text] [Related]
5. miRNAs-Based Molecular Signature for
Milanesi E; Dobre M; Bucuroiu AI; Herlea V; Manuc TE; Salvi A; De Petro G; Manuc M; Becheanu G
J Immunol Res; 2020; 2020():4927120. PubMed ID: 32676506
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
[TBL] [Abstract][Full Text] [Related]
8. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.
Bjeije H; Soltani BM; Behmanesh M; Zali MR
Hum Mol Genet; 2019 Oct; 28(19):3219-3231. PubMed ID: 31238337
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of LncRNA CASC2 mediated the cell viability, apoptosis and autophagy of colon cancer cells by sponging miR-19a via NF-κB signaling pathway.
Zhang P; Pan Y; Sun J; Pan G
Int J Exp Pathol; 2021 Jun; 102(3):163-171. PubMed ID: 33983643
[TBL] [Abstract][Full Text] [Related]
10. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis.
Zhao C; Zhao Q; Zhang C; Wang G; Yao Y; Huang X; Zhan F; Zhu Y; Shi J; Chen J; Yan F; Zhang Y
Sci Rep; 2017 Jun; 7(1):4194. PubMed ID: 28646148
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells.
Choo KB; Soon YL; Nguyen PN; Hiew MS; Huang CJ
J Biomed Sci; 2014 Oct; 21(1):95. PubMed ID: 25287248
[TBL] [Abstract][Full Text] [Related]
12. miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells.
Morimoto Y; Mizushima T; Wu X; Okuzaki D; Yokoyama Y; Inoue A; Hata T; Hirose H; Qian Y; Wang J; Miyoshi N; Takahashi H; Haraguchi N; Matsuda C; Doki Y; Mori M; Yamamoto H
Br J Cancer; 2020 Mar; 122(7):1037-1049. PubMed ID: 32066912
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
[TBL] [Abstract][Full Text] [Related]
14. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.
Zhang L; Dong Y; Zhu N; Tsoi H; Zhao Z; Wu CW; Wang K; Zheng S; Ng SS; Chan FK; Sung JJ; Yu J
Mol Cancer; 2014 May; 13():124. PubMed ID: 24885920
[TBL] [Abstract][Full Text] [Related]
15. miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR.
Tang YJ; Wu W; Chen QQ; Liu SH; Zheng ZY; Cui ZL; Xu JP; Xue Y; Lin DH
BMC Cancer; 2022 Aug; 22(1):909. PubMed ID: 35986311
[TBL] [Abstract][Full Text] [Related]
16. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
[TBL] [Abstract][Full Text] [Related]
17. MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.
McNew KL; Whipple WJ; Mehta AK; Grant TJ; Ray L; Kenny C; Singh A
Mol Cancer Res; 2016 Dec; 14(12):1204-1216. PubMed ID: 27655129
[TBL] [Abstract][Full Text] [Related]
18. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells.
Wang X; Zhao J; Huang J; Tang H; Yu S; Chen Y
Biochem Biophys Res Commun; 2012 Aug; 425(1):51-7. PubMed ID: 22820191
[TBL] [Abstract][Full Text] [Related]
19. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
[TBL] [Abstract][Full Text] [Related]
20. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.
Choe MH; Yoon Y; Kim J; Hwang SG; Han YH; Kim JS
Cell Death Dis; 2018 May; 9(6):640. PubMed ID: 29844307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
